Division of Molecular Medicine and Gene Therapy
51 – 60 of 623
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reprogramming Stars #18 : Engineering Cell Fates and Preventing Disease by Repressing Unwanted Plasticity-An Interview with Dr. Moritz Mall
- Contribution to journal › Letter
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
How to manage patients with germline DDX41 variants : Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
- Contribution to journal › Article
-
Mark
Orchestrating an immune response to cancer with cellular reprogramming
- Contribution to journal › Letter
- 2023
-
Mark
Reprogramming Stars #10 : Modeling Cancer with Cellular Reprogramming-An Interview with Dr. Dung-Fang Lee
- Contribution to journal › Debate/Note/Editorial
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
- Contribution to journal › Article
-
Mark
GATA2 mitotic bookmarking is required for definitive haematopoiesis
- Contribution to journal › Article
-
Mark
Evaluation of genetic demultiplexing of single-cell sequencing data from model species
- Contribution to journal › Article
-
Mark
MAC-1 marks a quiescent and functionally superior HSC subset during regeneration
- Contribution to journal › Article
-
Mark
Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia
- Contribution to journal › Article
